← Browse by Condition
Medical Condition
lymphoma
Total Trials
25
Recruiting Now
25
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 3
NCT06137144 Phase 1, Phase 2
Recruiting
AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.
Enrollment
110 pts
Location
United States, Austr...
Sponsor
AstraZeneca
NCT04739813 Phase 1
Recruiting
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
Enrollment
55 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT07305337
Recruiting
Randomised Controlled Trial of Artificial Intelligence-assisted Health Education
Enrollment
196 pts
Location
China
Sponsor
Zhongnan Hospital
NCT05006482 Phase 3
Recruiting
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
Enrollment
668 pts
Location
United States
Sponsor
University of Rochester
NCT07155954
Recruiting
Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes
Enrollment
779 pts
Location
China
Sponsor
Peking University Third Hospit...
NCT03580109
Recruiting
Spa Therapy for Upper or Lower Limb Lymphoedema
Enrollment
160 pts
Location
France
Sponsor
Association Francaise pour la ...
NCT05080166
Recruiting
UPLYFT For Lymphoma Survivors
Enrollment
74 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT07249905 Phase 1, Phase 2
Recruiting
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Enrollment
180 pts
Location
Australia
Sponsor
ModeX Therapeutics, An OPKO He...
NCT06550427
Recruiting
Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
Enrollment
200 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT06441331 Phase 1
Recruiting
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Enrollment
20 pts
Location
United States, Spain
Sponsor
ITM Solucin GmbH
NCT06131801
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
NCT05509751
Recruiting
The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person
Enrollment
60 pts
Location
Canada
Sponsor
Martine Puts
NCT06585124
Recruiting
Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas
Enrollment
150 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
NCT04510766
Recruiting
Tumor Molecular Profiling in Early Phase Clinical Trials
Enrollment
40 pts
Location
Switzerland
Sponsor
Oncology Institute of Southern...
NCT06421805
Recruiting
Establishing Prospective Mediastinal Tumor Database of PUMCH
Enrollment
2,000 pts
Location
China
Sponsor
Peking Union Medical College H...
NCT06895291
Recruiting
Whole Body MRI in Oncology
Enrollment
1,000 pts
Location
Italy
Sponsor
Istituto Romagnolo per lo Stud...
NCT05618041
Recruiting
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
Enrollment
50 pts
Location
China
Sponsor
Hebei Senlang Biotechnology In...
NCT06510361 Phase 2
Recruiting
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
Enrollment
35 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical ...
NCT07015242 Phase 2
Recruiting
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Enrollment
65 pts
Location
United States, Franc...
Sponsor
Juno Therapeutics, Inc., a Bri...
NCT05190653
Recruiting
Early Integration of Palliative and Supportive Care in Cellular Therapy
Enrollment
152 pts
Location
Canada
Sponsor
Alberta Health Services, Calga...
NCT00935090
Recruiting
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In...
NCT06563505 Phase 2
Recruiting
A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma
Enrollment
36 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT07086989
Recruiting
Cardiovascular Risk in Children With Chronic Conditions Study
Enrollment
300 pts
Location
Hungary
Sponsor
Semmelweis University
NCT06814925
Recruiting
Italian Study of Patients With Lymphoma
Enrollment
1,500 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
NCT06774326
Recruiting
Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines
Enrollment
160 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...